NEBNext is a registered trademark of New England Biolabs, Inc.Click on any of the CST antibodies below to see how we perform against the competition. Expert technical support is available from the same scientists who developed and validated the ChIP-seq antibodiesĬST has compared many of our ChIP-seq antibodies to ChIP-seq approved antibodies from other companies.Antibodies are compatible with other ChIP-seq protocols, allowing for use in ChIP kits from CST or other suppliers, and in customized lab protocols.Antibodies are tested and validated for target specificity across multiple applications, providing reduced non-specific binding and high signal-to-noise ratio in ChIP-seq.Antibodies are validated and optimized using the SimpleChIP Enzymatic Chromatin IP protocol, saving you time and money.All ChIP-seq approved antibodies from CST are recombinant rabbit monoclonal antibodies, providing greater lot-to-lot reproducibility.
Advantages of using ChIP-seq antibodies produced at CST are: Our ChIP-seq approved antibodies are tested using the SimpleChIP Enzymatic Chromatin IP protocol followed by next-generation sequencing (NGS). CST now tests and validates recombinant rabbit monoclonal antibodies in ChIP-seq, because good performance in ChIP-qPCR does not necessarily mean an antibody will perform well for ChIP-seq, which requires more extensive capture of the target protein across a large number of gene loci. Choosing an antibody that recognizes the correct target protein and does not show non-specific binding with other DNA-binding proteins is critical for a successful ChIP-seq experiment.
0 kommentar(er)
